Wei-Fen Xie
Shanghai Changzheng Hospital · Naval Medical University · Director of department of gastroenterology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Wei-Fen Xie as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:39 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT07381257 · Efficacy and Safety of Rifaximin-α in Treating MASLDShanghai Changzheng Hospital · recruiting · Metabolic Dysfunction-Associated Steatotic Liver Disease
- Ph2/Ph3NCT06847178 · Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 DiabetesShanghai Changzheng Hospital · not yet recruiting · Diabetes, Type 2 Diabetes · study director
- Ph2/Ph3NCT06696248 · Carvedilol and Alverine in Portal HypertensionShanghai Changzheng Hospital · not yet recruiting · Hypertension, Portal · principal investigator
- Early Ph1NCT06621173 · A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC PatientsShanghai Changzheng Hospital · recruiting · Metastatic Colorectal Cancer (mCRC) · principal investigator
- Ph2/Ph3NCT06473493 · The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal HypertensionShanghai Changzheng Hospital · unknown · Hypertension, Portal · principal investigator
- Ph2/Ph3NCT06470386 · The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver CirrhosisShanghai Changzheng Hospital · unknown · Hypertension, Portal · principal investigator
- Early Ph1NCT06418659 · A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC PatientsShanghai Changzheng Hospital · recruiting · Advanced Hepatocellular Carcinoma · principal investigator
- Early Ph1NCT06092112 · A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular CarcinomaShanghai Changzheng Hospital · completed · Advanced Hepatocellular Carcinoma · principal investigator
- Ph2NCT05508633 · The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot StudyShanghai Changzheng Hospital · enrolling by invitation · Portal Hypertension · principal investigator
- N/ANCT03195634 · WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver CirrhosisShanghai Changzheng Hospital · unknown · Portal Hypertension, Cirrhosis · principal investigator
- Ph4NCT02190357 · Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled TrialShanghai Changzheng Hospital · unknown · Cirrhosis · principal investigator
- Ph4NCT02074280 · Rifaximin Predicts the Complications of Decompensated CirrhosisShanghai Changzheng Hospital · unknown · Cirrhosis · principal investigator
- Ph4NCT01184690 · Single-Operator Versus Dual-Operator Double-balloon Endoscopy in Patients With Small-Bowel DisordersShanghai Changzheng Hospital · unknown · Small-Bowel Disorders · study director
- Ph4NCT01176864 · Double- Versus Single-balloon Enteroscopy for Obscure Small-bowel BleedingShanghai Changzheng Hospital · unknown · Small-Bowel Disorders · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:39 UTC. The ranking covers the 200 most relevant of 265 PubMed records, and a shared surname and initials can bring in a namesake. All 265 on PubMed
- 730 citationsRCR 17.8
- 587 citationsRCR 52.7
- ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.N Engl J Med · 2014583 citationsRCR 21.3
- An interferon-free antiviral regimen for HCV after liver transplantation.N Engl J Med · 2014338 citationsRCR 12.4
- Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.Clin Cancer Res · 2017255 citationsRCR 8.2
- Kidney damage causally affects the brain cortical structure: A Mendelian randomization study.EBioMedicine · 2021221 citationsRCR 13.9
- Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.Signal Transduct Target Ther · 2021213 citationsRCR 12.8
- Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.N Engl J Med · 2014209 citationsRCR 6.9
- 175 citationsRCR 5.3
- 158 citationsRCR 4.0